CORT logo

CORT Free Cash Flow

Annual FCF

$126.90 M
+$6.99 M+5.83%

December 31, 2023

Summary

Performance

1-Year Change

+5.83%

3-Year Change

-15.81%

5-Year Change

+10%

15-Year Change

+109.7%

CORT Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.27%
CORT annual free cash flow is higher than 90.27% of companies in Healthcare sector

High & Low

All-time High

$167.42 M
CORT annual free cash flow is currently -24.20% below its historical high of $167.42 million

3-Year Low

$119.91 M
CORT annual free cash flow is currently +5.83% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CORT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 14, 2025
CORT next annual earnings announcement is scheduled for Feb 14, 2025

OtherCORTcash flowmetrics:

Annual CFO

$127.04 M
CORT annual cash flow from operations is $127.04 million

Annual CFF

-$148.72 M
CORT annual cash flow from financing activities is -$148.72 million

Annual CFI

$90.91 M
CORT annual cash flow from investing activities is $90.91 million

Annual CAPEX

$139.00 K
CORT annual capital expenditures is $139.00 thousand

Quarterly FCF

$72.19 M
+$31.43 M+77.09%

September 30, 2024

Summary

Performance

3-Month Change

+77.09%

1-Year Change

+203.9%

3-Year Change

+116.43%

5-Year Change

+116.43%

CORT Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.17%
CORT quarterly free cash flow is higher than 92.17% of companies in Healthcare sector

High & Low

All-time High

$72.19 M
CORT quarterly free cash flow is currently at an all-time high

3-Year Low

$5.89 M
CORT quarterly free cash flow is currently +1126.33% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CORT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
CORT next earnings announcement is scheduled for Feb 14, 2025

OtherCORTcash flowmetrics:

Quarterly CFO

$73.83 M
CORT quarterly cash flow from operations is $73.83 million

Quarterly CFF

-$21.09 M
CORT quarterly cash flow from financing activities is -$21.09 million

Quarterly CFI

-$44.04 M
CORT quarterly cash flow from investing activities is -$44.04 million

Quarterly CAPEX

$1.64 M
CORT quarterly capital expenditures is $1.64 million

TTM FCF

$142.60 M
+$19.32 M+15.67%

September 30, 2024

Summary

Performance

3-Month Change

+15.67%

1-Year Change

+14.36%

3-Year Change

+18.93%

5-Year Change

+18.93%

CORT TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.6%
CORT TTM free cash flow is higher than 90.6% of companies in Healthcare sector

High & Low

All-time High

$177.36 M
CORT TTM free cash flow is currently -19.60% below its historical high of $177.36 million

3-Year Low

$110.63 M
CORT TTM free cash flow is currently +28.90% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CORT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
CORT next earnings announcement is scheduled for Feb 14, 2025

OtherCORTcash flowmetrics:

TTM CFO

$144.65 M
CORT TTM cash flow from operations is $144.65 million

TTM CFF

-$23.02 M
CORT TTM cash flow from financing activities is -$23.02 million

TTM CFI

-$96.15 M
CORT TTM cash flow from investing activities is -$96.15 million

TTM CAPEX

$2.05 M
CORT TTM capital expenditures is $2.05 million

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

$126.90 M
CORT annual free cash flow is $126.90 million

Annual CFO

$127.04 M
CORT annual cash flow from operations is $127.04 million

Annual CAPEX

$139.00 K
CORT annual capital expenditures is $139.00 thousand

CORT Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.8%+203.9%+14.4%
3 y3 years-15.8%+116.4%+18.9%
5 y5 years+10.0%+116.4%+18.9%

CORT Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-24.2%+5.8%at high+1126.3%-19.6%+28.9%
5 y5-year-24.2%+5.8%at high+1126.3%-19.6%+28.9%
alltimeall time-24.2%+207.9%at high+343.7%-19.6%+401.3%

Corcept Therapeutics Incorporated Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
$72.19 M(+77.1%)
$142.60 M(+15.7%)
Jun 2024
-
$40.77 M(+71.6%)
$123.28 M(-1.1%)
Mar 2024
-
$23.76 M(+303.5%)
$124.70 M(-1.7%)
Dec 2023
$126.90 M(+5.8%)
$5.89 M(-88.9%)
$126.90 M(-17.8%)
Sep 2023
-
$52.87 M(+25.3%)
$154.37 M(+14.5%)
Jun 2023
-
$42.18 M(+62.5%)
$134.79 M(+21.8%)
Mar 2023
-
$25.96 M(-22.2%)
$110.63 M(-7.7%)
Dec 2022
$119.91 M(-28.4%)
$33.36 M(+0.2%)
$119.91 M(-11.8%)
Sep 2022
-
$33.30 M(+84.8%)
$135.91 M(-10.1%)
Jun 2022
-
$18.02 M(-48.9%)
$151.16 M(-14.8%)
Mar 2022
-
$35.23 M(-28.6%)
$177.36 M(+5.9%)
Dec 2021
$167.42 M(+11.1%)
$49.36 M(+1.7%)
$167.42 M(+9.6%)
Sep 2021
-
$48.55 M(+9.8%)
$152.70 M(+14.1%)
Jun 2021
-
$44.22 M(+74.8%)
$133.88 M(-6.2%)
Mar 2021
-
$25.30 M(-27.0%)
$142.80 M(-5.3%)
Dec 2020
$150.73 M(+11.6%)
$34.64 M(+16.5%)
$150.73 M(-8.3%)
Sep 2020
-
$29.73 M(-44.1%)
$164.41 M(-4.9%)
Jun 2020
-
$53.14 M(+59.9%)
$172.83 M(+19.3%)
Mar 2020
-
$33.23 M(-31.2%)
$144.83 M(+7.3%)
Dec 2019
$135.03 M(+17.0%)
$48.32 M(+26.7%)
$135.03 M(+24.9%)
Sep 2019
-
$38.14 M(+51.7%)
$108.12 M(-5.5%)
Jun 2019
-
$25.14 M(+7.3%)
$114.44 M(+9.6%)
Mar 2019
-
$23.42 M(+9.4%)
$104.44 M(-9.5%)
Dec 2018
$115.37 M(+90.6%)
$21.41 M(-51.9%)
$115.37 M(-2.9%)
Sep 2018
-
$44.46 M(+193.5%)
$118.81 M(+39.5%)
Jun 2018
-
$15.15 M(-55.9%)
$85.20 M(-0.3%)
Mar 2018
-
$34.35 M(+38.2%)
$85.42 M(+41.1%)
Dec 2017
$60.52 M(+232.6%)
$24.85 M(+129.2%)
$60.52 M(+50.7%)
Sep 2017
-
$10.84 M(-29.4%)
$40.16 M(+5.2%)
Jun 2017
-
$15.37 M(+62.6%)
$38.16 M(+56.6%)
Mar 2017
-
$9.45 M(+110.3%)
$24.37 M(+33.9%)
Dec 2016
$18.20 M(+484.5%)
$4.49 M(-49.2%)
$18.20 M(+1.8%)
Sep 2016
-
$8.85 M(+458.7%)
$17.88 M(+80.3%)
Jun 2016
-
$1.58 M(-51.7%)
$9.92 M(+21.0%)
Mar 2016
-
$3.27 M(-21.7%)
$8.20 M(+163.4%)
Dec 2015
$3.11 M(-111.3%)
$4.18 M(+373.4%)
$3.11 M(-226.0%)
Sep 2015
-
$883.00 K(-735.3%)
-$2.47 M(-73.4%)
Jun 2015
-
-$139.00 K(-92.3%)
-$9.30 M(-48.9%)
Mar 2015
-
-$1.81 M(+29.1%)
-$18.19 M(-34.0%)
Dec 2014
-$27.55 M(-25.9%)
-$1.40 M(-76.4%)
-$27.55 M(-18.6%)
Sep 2014
-
-$5.95 M(-34.2%)
-$33.85 M(-7.4%)
Jun 2014
-
-$9.03 M(-19.1%)
-$36.58 M(-0.6%)
Mar 2014
-
-$11.17 M(+45.0%)
-$36.78 M(-1.1%)
DateAnnualQuarterlyTTM
Dec 2013
-$37.19 M(+2.8%)
-$7.71 M(-11.1%)
-$37.19 M(-2.9%)
Sep 2013
-
-$8.67 M(-6.2%)
-$38.28 M(-1.6%)
Jun 2013
-
-$9.24 M(-20.2%)
-$38.89 M(+3.5%)
Mar 2013
-
-$11.57 M(+31.5%)
-$37.58 M(+3.9%)
Dec 2012
-$36.17 M(+31.9%)
-$8.80 M(-5.2%)
-$36.17 M(+7.4%)
Sep 2012
-
-$9.28 M(+17.1%)
-$33.66 M(+8.6%)
Jun 2012
-
-$7.93 M(-22.0%)
-$30.99 M(+2.4%)
Mar 2012
-
-$10.16 M(+61.5%)
-$30.27 M(+10.5%)
Dec 2011
-$27.43 M(+23.1%)
-$6.29 M(-4.7%)
-$27.40 M(+3.2%)
Sep 2011
-
-$6.60 M(-8.4%)
-$26.56 M(+0.7%)
Jun 2011
-
-$7.21 M(-1.2%)
-$26.38 M(+11.4%)
Mar 2011
-
-$7.29 M(+33.7%)
-$23.69 M(+6.3%)
Dec 2010
-$22.29 M(+24.0%)
-$5.46 M(-15.1%)
-$22.29 M(+5.1%)
Sep 2010
-
-$6.43 M(+42.3%)
-$21.21 M(+14.6%)
Jun 2010
-
-$4.52 M(-23.3%)
-$18.51 M(-8.3%)
Mar 2010
-
-$5.89 M(+34.4%)
-$20.19 M(+12.4%)
Dec 2009
-$17.97 M(-2.2%)
-$4.38 M(+17.5%)
-$17.97 M(-0.6%)
Sep 2009
-
-$3.73 M(-39.8%)
-$18.08 M(-1.2%)
Jun 2009
-
-$6.20 M(+69.1%)
-$18.30 M(+4.3%)
Mar 2009
-
-$3.66 M(-18.5%)
-$17.56 M(-4.4%)
Dec 2008
-$18.37 M(+67.5%)
-$4.49 M(+13.7%)
-$18.36 M(+7.5%)
Sep 2008
-
-$3.95 M(-27.5%)
-$17.09 M(+17.9%)
Jun 2008
-
-$5.45 M(+21.9%)
-$14.50 M(+22.7%)
Mar 2008
-
-$4.47 M(+38.8%)
-$11.81 M(+7.7%)
Dec 2007
-$10.96 M(-55.3%)
-$3.22 M(+135.9%)
-$10.96 M(-17.5%)
Sep 2007
-
-$1.36 M(-50.6%)
-$13.29 M(-23.6%)
Jun 2007
-
-$2.76 M(-23.8%)
-$17.39 M(-17.8%)
Mar 2007
-
-$3.62 M(-34.7%)
-$21.15 M(-9.0%)
Dec 2006
-$24.55 M(-43.0%)
-$5.54 M(+1.5%)
-$23.24 M(-50.9%)
Sep 2006
-
-$5.46 M(-16.3%)
-$47.32 M(+4.8%)
Jun 2006
-
-$6.52 M(+14.2%)
-$45.17 M(+4.8%)
Mar 2006
-
-$5.71 M(-80.7%)
-$43.09 M(-0.0%)
Dec 2005
-$43.10 M(-63.4%)
-$29.63 M(+795.4%)
-$43.10 M(+134.6%)
Sep 2005
-
-$3.31 M(-25.5%)
-$18.37 M(-0.7%)
Jun 2005
-
-$4.44 M(-22.2%)
-$18.50 M(+7.5%)
Mar 2005
-
-$5.71 M(+16.6%)
-$17.21 M(+25.4%)
Dec 2004
-$117.62 M(+1075.8%)
-$4.90 M(+42.6%)
-$13.72 M(+32.6%)
Sep 2004
-
-$3.44 M(+9.1%)
-$10.34 M(+17.3%)
Jun 2004
-
-$3.15 M(+41.6%)
-$8.82 M(-3.6%)
Mar 2004
-
-$2.23 M(+45.6%)
-$9.14 M(-8.6%)
Dec 2003
-$10.00 M
-$1.53 M(-20.1%)
-$10.00 M(+18.0%)
Sep 2003
-
-$1.91 M(-45.0%)
-$8.47 M(+29.1%)
Jun 2003
-
-$3.48 M(+12.7%)
-$6.56 M(+112.7%)
Mar 2003
-
-$3.09 M
-$3.09 M

FAQ

  • What is Corcept Therapeutics Incorporated annual free cash flow?
  • What is the all time high annual FCF for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated annual FCF year-on-year change?
  • What is Corcept Therapeutics Incorporated quarterly free cash flow?
  • What is the all time high quarterly FCF for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated quarterly FCF year-on-year change?
  • What is Corcept Therapeutics Incorporated TTM free cash flow?
  • What is the all time high TTM FCF for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated TTM FCF year-on-year change?

What is Corcept Therapeutics Incorporated annual free cash flow?

The current annual FCF of CORT is $126.90 M

What is the all time high annual FCF for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high annual free cash flow is $167.42 M

What is Corcept Therapeutics Incorporated annual FCF year-on-year change?

Over the past year, CORT annual free cash flow has changed by +$6.99 M (+5.83%)

What is Corcept Therapeutics Incorporated quarterly free cash flow?

The current quarterly FCF of CORT is $72.19 M

What is the all time high quarterly FCF for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high quarterly free cash flow is $72.19 M

What is Corcept Therapeutics Incorporated quarterly FCF year-on-year change?

Over the past year, CORT quarterly free cash flow has changed by +$48.44 M (+203.90%)

What is Corcept Therapeutics Incorporated TTM free cash flow?

The current TTM FCF of CORT is $142.60 M

What is the all time high TTM FCF for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high TTM free cash flow is $177.36 M

What is Corcept Therapeutics Incorporated TTM FCF year-on-year change?

Over the past year, CORT TTM free cash flow has changed by +$17.90 M (+14.36%)